2026 Hugo Mouquet: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	65	2804	2585	121	109	157	23567

Overview

Hugo Mouquet is affiliated with the Institut Pasteur in France and has an extensive research portfolio primarily centered on infectious diseases, immunology, and molecular biology with a strong focus on SARS-CoV-2 and COVID-19 research. Mouquet's work spans multiple interconnected fields, including medicine, immunology and microbiology, infectious diseases, virology, epidemiology, and molecular biology.

The scientist's recent publications highlight investigations into SARS-CoV-2 variants and immune response mechanisms. Notable papers include:

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization, 2021, Nature
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization, 2021, Nature
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies, 2021, Nature Medicine
Syncytia formation by SARS-CoV-2-infected cells, 2020, The EMBO Journal
Syncytia formation by SARS-CoV-2-infected cells, 2021, The EMBO Journal

Mouquet has collaborated frequently with several researchers, which include Cyril Planchais, Olivier Schwartz, Timothée Bruel, Delphine Planas, and Isabelle Staropoli. These collaborations reflect an active engagement in scientific networks focusing on immunology and viral pathogenesis.

Mouquet's publication record shows a preference for disseminating findings in recognized scientific journals and preprint servers. Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Nature, Cell Host & Microbe, and iScience.

The main research topics embodied in Mouquet's work encompass:

SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Immune Cell Function and Interaction
SARS-CoV-2 detection and testing
HIV Research and Treatment
T-cell and B-cell Immunology
Monoclonal and Polyclonal Antibodies Research

Mouquet's contributions are positioned at the intersection of clinical and experimental immunology, focusing on how immune systems respond to viral infections and how antibody neutralization varies with evolving SARS-CoV-2 variants. The research has implications for understanding viral escape mechanisms and immune protection, key to therapeutic and vaccine strategies.

Best Publications

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Unknown

2699
Citations
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Delphine Planas;David Veyer;Artem Baidaliuk;Isabelle Staropoli

1920
Citations
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin

1401
Citations
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman

1043
Citations
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Delphine Planas;Delphine Planas;Timothée Bruel;Timothée Bruel;Ludivine Grzelak;Florence Guivel-Benhassine;Florence Guivel-Benhassine

678
Citations
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.

Hugo Mouquet;Louise Scharf;Zelda Euler;Yan Liu

666
Citations
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

Florian Klein;Ron Diskin;Ron Diskin;Johannes F. Scheid;Johannes F. Scheid;Christian Gaebler;Christian Gaebler

638
Citations
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

592
Citations
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

Florian Klein;Ariel Halper-Stromberg;Joshua A. Horwitz;Henning Gruell;Henning Gruell

588
Citations
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet

582
Citations
Antibodies in HIV-1 Vaccine Development and Therapy

Florian Klein;Hugo Mouquet;Pia Dosenovic;Johannes F. Scheid

562
Citations
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies

Unknown

538
Citations
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

Pascal Joly;Hugo Mouquet;Jean-Claude Roujeau;Michel D'Incan

530
Citations
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey;Till Schoofs;Henning Gruell;Allison Settler

517
Citations
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

Hugo Mouquet;Johannes F. Scheid;Johannes F. Scheid;Markus J. Zoller;Michelle Krogsgaard

492
Citations
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

Guillaume Darrasse-Jèze;Stephanie Deroubaix;Hugo Mouquet;Gabriel D. Victora

482
Citations
Syncytia formation by SARS-CoV-2-infected cells.

Julian Buchrieser;Julian Buchrieser;Jérémy Dufloo;Jérémy Dufloo;Jérémy Dufloo;Mathieu Hubert;Mathieu Hubert;Blandine Monel;Blandine Monel

382
Citations
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

Masashi Shingai;Olivia K. Donau;Ronald J. Plishka;Alicia Buckler-White

374
Citations
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

Matthew R. Gardner;Lisa M. Kattenhorn;Hema R. Kondur;Markus von Schaewen

357
Citations
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

Joshua A. Horwitz;Ariel Halper-Stromberg;Hugo Mouquet;Alexander D. Gitlin

308
Citations
A method for identification of HIV gp140 binding memory B cells in human blood.

Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Bruce D. Walker

253
Citations
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

242
Citations

Frequent Co-Authors

Olivier Schwartz Université Paris Cité

Michel C. Nussenzweig Rockefeller University

Pamela J. Bjorkman California Institute of Technology

Michael S. Seaman Beth Israel Deaconess Medical Center

Sylvie van der Werf Université Paris Cité

James P. Di Santo Institut Pasteur

Darragh Duffy Institut Pasteur

Pierre Charneau Institut Pasteur

Arnaud Fontanet Institut Pasteur

Alain Fischer Collège de France

External Links

Personal website of Hugo Mouquet

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in advancing their careers alongside immunology, exploring nursing programs can be a practical step. Many aspiring healthcare professionals often seek the lpn programs easy to get into as a foundation. These programs provide essential clinical skills and can serve as a stepping stone to more advanced roles.

Nurse Practitioner roles are particularly relevant for those aiming to specialize further. You might consider some of the easiest np programs to get into, which offer accessible pathways to gain advanced clinical training.

Specializing in mental health is also a growing avenue, where programs like the pmhnp programs online with best clinical placement can provide valuable hands-on experience and better career outcomes.

Cost is an important factor for many students. Exploring the cheapest psychiatric nurse practitioner programs can ensure quality education without breaking the bank, making advanced healthcare degrees more accessible.